(Q47755685)

5 February 2018

title

The advanced-DiaRem score improves prediction of diabetes remission 1 year post-Roux-en-Y gastric bypass. (English)

1 reference

5 February 2018

14

Karine Clément

1 reference

5 February 2018

8

Jean-Michel Oppert

1 reference

5 February 2018

13

Assaf Rudich

1 reference

PubMed ID

28733906

5 February 2018

Judith Aron-Wisnewsky

1

object named as

Judith Aron-Wisnewsky

1 reference

5 February 2018

author name string

Nataliya Sokolovska

2

1 reference

5 February 2018

Yuejun Liu

3

1 reference

5 February 2018

Doron S Comaneshter

4

1 reference

5 February 2018

Shlomo Vinker

5

1 reference

5 February 2018

Tal Pecht

6

1 reference

5 February 2018

Christine Poitou

7

1 reference

5 February 2018

Jean-Luc Bouillot

9

1 reference

5 February 2018

Laurent Genser

10

1 reference

5 February 2018

Dror Dicker

11

1 reference

5 February 2018

Jean-Daniel Zucker

12

1 reference

5 February 2018

publication date

21 July 2017

1 reference

5 February 2018

published in

Diabetologia

1 reference

5 February 2018

volume

60

1 reference

5 February 2018

issue

10

1 reference

5 February 2018

page(s)

1892-1902

1 reference

5 February 2018

https://scigraph.springernature.com/pub.10.1007/s00125-017-4371-7

exact match

0 references

cites work

How do we define cure of diabetes?

1 reference

https://api.crossref.org/works/10.1007%2FS00125-017-4371-7

Metabolic Surgery in the Treatment Algorithm for Type 2 Diabetes: A Joint Statement by International Diabetes Organizations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-017-4371-7

Bariatric Surgery Worldwide 2013.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-017-4371-7

Clinical Outcomes of Metabolic Surgery: Efficacy of Glycemic Control, Weight Loss, and Remission of Diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-017-4371-7

Effect of the definition of type II diabetes remission in the evaluation of bariatric surgery for metabolic disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-017-4371-7

Long-term diabetic response to gastric bypass

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-017-4371-7

Bariatric-metabolic surgery versus conventional medical treatment in obese patients with type 2 diabetes: 5 year follow-up of an open-label, single-centre, randomised controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-017-4371-7

Nutritional and Protein Deficiencies in the Short Term following Both Gastric Bypass and Gastric Banding

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-017-4371-7

A model for predicting the resolution of type 2 diabetes in severely obese subjects following Roux-en Y gastric bypass surgery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-017-4371-7

Statistical models to predict type 2 diabetes remission after bariatric surgery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-017-4371-7

Preoperative prediction of type 2 diabetes remission after Roux-en-Y gastric bypass surgery: a retrospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-017-4371-7

Accumulation and Changes in Composition of Collagens in Subcutaneous Adipose Tissue After Bariatric Surgery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-017-4371-7

Long-Term Outcomes of Three Types of Bariatric Surgery on Obesity and Type 2 Diabetes Control and Remission.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-017-4371-7

(2) Classification and diagnosis of diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-017-4371-7

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-017-4371-7

Adipocyte turnover: relevance to human adipose tissue morphology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-017-4371-7

Fibrosis in human adipose tissue: composition, distribution, and link with lipid metabolism and fat mass loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-017-4371-7

Histopathological algorithm and scoring system for evaluation of liver lesions in morbidly obese patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-017-4371-7

Systematic review of bariatric surgery liver biopsies clarifies the natural history of liver disease in patients with severe obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-017-4371-7

Bariatric surgery for type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-017-4371-7

Diabetes complications in childhood and adolescent onset type 2 diabetes-a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-017-4371-7

A multisite study of long-term remission and relapse of type 2 diabetes mellitus following gastric bypass.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-017-4371-7

Bariatric surgery versus intensive medical therapy for diabetes--3-year outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-017-4371-7

Assessing the potential for alpha-glucosidase inhibitors in prediabetic states.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-017-4371-7

Improvement in glycated haemoglobin evaluated by baseline body mass index: a meta-analysis of the liraglutide phase III clinical trial programme

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-017-4371-7

Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-017-4371-7

Usefulness of measuring both body mass index and waist circumference for the estimation of visceral adiposity and related cardiometabolic risk profile (from the INSPIRE ME IAA study).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-017-4371-7

Differential adaptation of human gut microbiota to bariatric surgery-induced weight loss: links with metabolic and low-grade inflammation markers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-017-4371-7

The effects of gastrointestinal surgery on gut microbiota: potential contribution to improved insulin sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-017-4371-7

Analysis of factors associated with durable remission of diabetes after Roux-en-Y gastric bypass

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-017-4371-7

Can we prevent beta cell apoptosis in type 2 diabetes?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-017-4371-7

Bariatric Surgery versus Intensive Medical Therapy for Diabetes - 5-Year Outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-017-4371-7

Interdisciplinary European guidelines on metabolic and bariatric surgery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-017-4371-7

Clinical practice guidelines for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient--2013 update: cosponsored by American Association of Clinical Endocrinologists, The Obesity Society, and American Soc

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-017-4371-7

Association of Adipose Tissue and Liver Fibrosis With Tissue Stiffness in Morbid Obesity: Links With Diabetes and BMI Loss After Gastric Bypass

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-017-4371-7

U.K. prospective diabetes study 16. Overview of 6 years' therapy of type II diabetes: a progressive disease. U.K. Prospective Diabetes Study Group

21 January 2018

1 reference

12 December 2020

Predicting success of metabolic surgery: age, body mass index, C-peptide, and duration score

1 reference

12 December 2020

Type 2 Diabetes Remission After Gastric Bypass: What Is the Best Prediction Tool for Clinicians?

1 reference

12 December 2020

DiaRem score: external validation

1 reference

12 December 2020

Micronutrient and Protein Deficiencies After Gastric Bypass and Sleeve Gastrectomy: a 1-year Follow-up

1 reference

12 December 2020

Weight change and health outcomes at 3 years after bariatric surgery among individuals with severe obesity

1 reference

12 December 2020

Preoperative Prediction of Type 2 Diabetes Remission After Gastric Bypass Surgery: a Comparison of DiaRem Scores and ABCD Scores

1 reference

12 December 2020

Standards of Medical Care in Diabetes-2017: Summary of Revisions

1 reference

12 December 2020

Dynamics of change in total and regional body composition after gastric bypass in obese patients

1 reference

12 December 2020

10.1007/S00125-017-4371-7

Identifiers

DOI

1 reference

5 February 2018

PubMed ID

28733906

1 reference

5 February 2018